Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of direct-to-consumer genomewide profiling to assess disease risk.

The New England journal of medicine - 10 Feb 2011

Bloss Cinnamon S, Schork Nicholas J, Topol Eric J

Abstract excerpt

BACKGROUND: The use of direct-to-consumer genomewide profiling to assess disease risk is controversial, and little is known about the effect of this technology on consumers. We examined the psychological, behavioral, and clinical effects of risk scanning with the Navigenics Health Compass, a commercially available test of uncertain clinical validity and utility. METHODS: We recruited subjects from health and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anxiety
Share to Commerce
Share to Dietary Fats

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exercise

Share to Genetic Counseling

Share to Genome, Human

Share to Health Behavior

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 21226570
DOI: 10.1056/NEJMoa1011893
PMCID: PMC3786730

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of direct-to-consumer genomewide profiling to assess disease risk.PMID 21226570Read ↗

Impact of direct-to-consumer genomic testing at long term follow-up.Semantic proximity Read ↗

Direct-to-Consumer Personal Genome Testing and Cancer Risk PredictionSemantic proximity Read ↗

Consumer perceptions of direct-to-consumer personalized genomic risk assessments.Semantic proximity Read ↗

The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study.Semantic proximity Read ↗

Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation.Semantic proximity Read ↗

Personal Genomic Testing for Cancer Risk: Results From the Impact of Personal Genomics Study.Semantic proximity Read ↗

Direct-To-Consumer Genetic Testing: Where and How Does Genetic Counseling Fit?Semantic proximity Read ↗

State of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation.Semantic proximity Read ↗

Direct‐to‐consumer genetic testing: good, bad or benign?Semantic proximity Read ↗

The regulation of direct-to-consumer genetic tests.Semantic proximity Read ↗

[The genome and the consumer].Semantic proximity Read ↗

Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.